News | Artificial Intelligence | November 25, 2025

Partnership expands U.S. access to Avicenna’s advanced imaging AI solutions through Ferrum’s AI Governance Suite. Avicenna.AI will be attending RSNA 2025.

Avicenna.AI, Ferrum Health Partner to Expand U.S. Access to Advanced Medical Imaging AI

Nov. 25, 2025  Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI Governance Suite supporting more than 50 industry-leading algorithms. Under the agreement, Ferrum will now commercialize Avicenna.AI’s full portfolio of imaging AI solutions across the United States.

Ferrum’s suite gives clinicians access to advanced AI technologies designed to enhance diagnostic accuracy across oncology, women’s and men’s health, cardiovascular care, neurology, orthopedics and more. By adding Avicenna’s emergency and high-impact imaging solutions to its expanding library, Ferrum strengthens its position as one of the most comprehensive AI marketplaces in healthcare.

Avicenna.AI delivers a full suite of deep learning solutions designed to detect, identify, and quantify life-threatening conditions from CT imaging. Its CINA solutions support radiologists by accelerating the detection of critical findings, prioritizing urgent cases, enhancing workflow efficiency, and improving patient outcomes.

The portfolio includes AI solutions for:

  • Intracranial hemorrhage (CINA-ICH)
  • Large vessel occlusion (CINA-LVO)
  • Aortic dissection (CINA-AD)
  • Pulmonary embolism (CINA-PE and CINA-iPE)
  • Vertebral compression fractures (CINA-VCF)
  • Cervical spine fractures (CINA-CSpine)
  • ASPECT scoring for stroke severity (CINA-ASPECTS)

Ferrum’s platform allows clinicians to validate AI performance on local datasets and integrate AI directly into existing workflows - without protected health information (PHI) ever leaving the health system’s firewall.

“Radiologists and clinicians are asking for AI that truly moves the needle for patients,” said Pelu Tran, CEO of Ferrum Health. “Partnering with Avicenna.AI lets us put some of the most trusted emergency imaging tools directly into the hands of the health systems we serve, expanding access to life-saving technology across the U.S.”

“Our mission is to make high-performance, clinically proven AI accessible to as many clinicians as possible,” said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “Ferrum’s enterprise-ready platform is the ideal partner to accelerate U.S. adoption and ensure our solutions are deployed safely, efficiently, and at scale.”

Avicenna.AI will be attending RSNA 2025 with a strong presence throughout the show, offering demonstrations and presentations alongside multiple partners. To book a meeting with the company, visit: https://meetings-eu1.hubspot.com/martijn-jonkers/rsna-2025-meet-with-avicennaai


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | RSNA

The Nominating Committee for the Radiological Society for North America (RSNA) is seeking nominations for qualified ...

Time February 12, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
Subscribe Now